Medindia LOGIN REGISTER
Medindia
Advertisement

Varian Completes Purchase of Embolic Bead Asset

Thursday, August 22, 2019 General News
Advertisement
PALO ALTO, Calif., Aug. 21, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it has successfully completed its asset purchase of the Boston Scientific portfolio of drug-loadable microsphere and bland embolic bead products for treating arteriovenous malformations and hypervascular tumors. This acquisition expands the portfolio of Varian interventional oncology solutions. To view the original announcement from July 2, 2019, visit: https://www.varian.com/news/varian-expand-interventional-oncology-portfolio-purchase-embolic-bead-asset.
Advertisement

About Varian At Varian, we envision a world without fear of cancer. For more than 70 years, we have developed, built and delivered innovative cancer care technologies and solutions for our clinical partners around the globe to help them treat millions of patients each year. With an Intelligent Cancer Care approach, we are harnessing advanced technologies like artificial intelligence, machine learning and data analytics to enhance cancer treatment and expand access to care. Our 9,200 employees across 70 countries keep the patient and our clinical partners at the center of our thinking as we power new victories in cancer care. Because, for cancer patients everywhere, their fight is our fight. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.
Advertisement

Press ContactMark PlungyDirector, Global Public Relations+1 (650) 424-5630 [email protected]

Investor Relations ContactJ. Michael BruffSenior Vice President, Investor Relations+1 (650) 424-5163 [email protected]

 

Cision View original content:http://www.prnewswire.com/news-releases/varian-completes-purchase-of-embolic-bead-asset-300905358.html

SOURCE Varian

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close